Research Paper Volume 13, Issue 16 pp 20661—20683
METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
Figure 5. KEGG and GO analysis of DEGs between low and high METTL21B expression groups. KEGG analysis of DEGs (A, B); GO analysis of DEGs (C, D).